Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TREDEGAR CORP Director's Dealing 2020

Dec 24, 2020

33445_dirs_2020-12-23_1802e22c-d7c4-4794-b442-30a4f4ab8073.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TREDEGAR CORP (TG)
CIK: 0000850429
Period of Report: 2020-12-21

Reporting Person: GOTTWALD JOHN D (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-21 Stock Option (right to buy) $14.43 J 484110 Acquired 2025-05-07 Common Stock (484110) Direct
2020-12-21 Stock Option (right to buy) $13.78 J 517655 Acquired 2026-03-23 Common Stock (517655) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Tredegar Common Stock 1895698 Direct
Tredegar Common Stock 12953 Indirect
Tredegar Common Stock 4935 Indirect
Tredegar Common Stock 90000 Indirect
Tredegar Common Stock 28684 Indirect
Tredegar Common Stock 850928 Indirect
Tredegar Common Stock 142365 Indirect

Footnotes

F1: Held by wife. (Reporting person disclaims beneficial ownership.)

F2: Held for Sarah Wren Gottwald U/A dated 3-1-83, W. M. Gottwald and J. D. Gottwald, trustees. (Reporting person disclaims beneficial ownership.)

F3: Held by Thomas McN. Millhiser and James T. Gottwald, as trustees, of the John D. Gottwald Family Trust, FBO reporting person's children, U/A dated 4-10-92. (Reporting person disclaims beneficial ownership.)

F4: Held by W. M. Gottwald as trustee FBO Margaret A. Gottwald U/A dated 3-09-92. (Reporting person disclaims beneficial ownership.)

F5: Held as co-trustee FBO (among others) reporting person's family u/w Floyd D. Gottwald.

F6: Held as co-trustee of the William M. Gottwald Trust U/A dated 8-16-90. (Reporting person disclaims beneficial ownership.)

F7: On December 18, 2020, the Issuer paid a special dividend of $5.97 per share to all holders of its common stock as of the close of business on December 11, 2020 (the "Special Dividend"). In connection with the Special
Dividend, the Executive Compensation Committee of the Issuer's Board of Directors (the "Committee") approved adjustments to the exercise price and number of shares subject to all unexercised stock options to account for the
effect of the Special Dividend.

F8: The original grant was for 361,011 shares with an exercise price of $19.35 per share.

F9: The original grant was for 386,026 shares with an exercise price of $18.48 per share.